Literature DB >> 15158760

Calmodulin antagonist W-7 inhibits de novo synthesis of cholesterol and suppresses secretion of de novo synthesized and preformed lipids from cultured hepatocytes.

Mehdi Rasouli1, Timothy C Trischuk, Richard Lehner.   

Abstract

The effects of a calmodulin antagonist W-7 were studied on the synthesis and secretion of lipids in primary rat hepatocytes and McArdle-RH7777 cells. In time course experiments, W-7 (20 microM) inhibited secretion of newly synthesized triacyl[(3)H]glycerol by 35%. When the cells were pre-treated overnight with W-7 (20 microM), followed by incubation with [(3)H]oleate, a significant decrease in the secretion of triacylglycerol (TG) and cholesteryl ester (CE) was observed. De novo synthesis of cholesterol from acetate or mevalonolactone was inhibited by W-7, but not glycerolipid synthesis from glycerol and oleic acid precursors. Concentration-response curves for the effects of overnight pre-incubation with W-7 followed labeling with [(3)H]glycerol and [(14)C]mevalonolactone revealed that: (1). the inhibitory effect of W-7 was concentration-dependent and appeared even at the lowest concentration examined (1 microM). W-7 at a concentration of 20 microM suppressed secretion of TG by 60% (P<or=0.002), phosphatidylcholine (PC) by 31% (P<or=0.05), CE by 59% (P<or=0.002) and cholesterol by 64% (P<or=0.002). (2). The incorporation of [(14)C]mevalonolactone into cellular cholesterol and CE was decreased significantly, while W-7 did not have any significant effect upon incorporation of [(3)H]glycerol into glycerolipids, except at the highest concentration examined (50 microM), where synthesis of both TG and PC was significantly suppressed. (3). While the percentage of secreted de novo synthesized glycerolipids and CE decreased proportionally with increasing concentration of W-7, the percentage of secreted newly made cholesterol remained unaffected at any concentration of W-7. In the absence of W-7, about 19% of newly formed cholesterol became esterified into CE, whereas W-7 increased cholesterol esterification in a concentration-dependent manner. (4) W-7 (20 microM) also suppressed the secretion of preformed cholesterol by 24% and CE by 55% but did not affect the recruitment of preformed cholesterol for esterification. About 6.5% of pre-labeled cholesterol and 20% of CE were directed to secretion, which was suppressed in the presence of W-7 by 17% (P<or=0.09) and 48% (P<or=0.001), respectively. These results suggest that, W-7 in the range of 1-20 microM inhibited de novo synthesis of cholesterol and the secretion of both de novo synthesized and preformed lipids.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15158760     DOI: 10.1016/j.bbalip.2004.02.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  Calmodulin antagonizes a calcium-activated SCF ubiquitin E3 ligase subunit, FBXL2, to regulate surfactant homeostasis.

Authors:  Bill B Chen; Tiffany A Coon; Jennifer R Glasser; Rama K Mallampalli
Journal:  Mol Cell Biol       Date:  2011-02-22       Impact factor: 4.272

2.  Suppression of cytochrome P450 reductase (POR) expression in hepatoma cells replicates the hepatic lipidosis observed in hepatic POR-null mice.

Authors:  Todd D Porter; Subhashis Banerjee; Elzbieta I Stolarczyk; Ling Zou
Journal:  Drug Metab Dispos       Date:  2011-03-02       Impact factor: 3.922

3.  Calculation of LDL-Cholesterol vs. Direct Homogenous Assay.

Authors:  Mehdi Rasouli; Hossein Mokhtari
Journal:  J Clin Lab Anal       Date:  2016-09-06       Impact factor: 2.352

4.  The Long Term Kinetic of Plasma Lipids and Lipoproteins in Tyloxapol Injected Rats.

Authors:  Mehdi Rasouli; Hanieh Tahmouri; Mahboobeh Mosavi-Mehr
Journal:  J Clin Diagn Res       Date:  2016-06-01

5.  Life Psychosocial Stresses and Coronary Artery Disease.

Authors:  Babak Bagheri; Fatemeh Meshkini; Kolsoum Dinarvand; Zahra Alikhani; Mal Haysom; Mehdi Rasouli
Journal:  Int J Prev Med       Date:  2016-09-14

6.  The Ratio of Unesterified/esterified Cholesterol is the Major Determinant of Atherogenicity of Lipoprotein Fractions.

Authors:  Babak Bagheri; Asal Alikhani; Hossein Mokhtari; Mehdi Rasouli
Journal:  Med Arch       Date:  2018-04

7.  Esterification of HDL-cholesterol is Decreased in Diabetes Mellitus and CAD and Enhanced Following Treatment with Statins.

Authors:  Babak Bagheri; Asal Alikhani; Hossein Mokhtari; Mehdi Rasouli
Journal:  Med Arch       Date:  2018-06

8.  Serum Creatinine and Occurrence and Severity of Coronary Artery Disease.

Authors:  Babak Bagheri; Najme Radmard; Atena Faghani-Makrani; Mehdi Rasouli
Journal:  Med Arch       Date:  2019-06

9.  Exploration of Blood Lipoprotein and Lipid Fraction Profiles in Healthy Subjects through Integrated Univariate, Multivariate, and Network Analysis Reveals Association of Lipase Activity and Cholesterol Esterification with Sex and Age.

Authors:  Yasmijn Balder; Alessia Vignoli; Leonardo Tenori; Claudio Luchinat; Edoardo Saccenti
Journal:  Metabolites       Date:  2021-05-18

10.  Fixed-time and continuous assays of very-low-density lipoprotein secretion rate from rat liver: mean vs. instantaneous velocity.

Authors:  Kousar Daneshnia; Mehdi Rasouli
Journal:  Clin Exp Hepatol       Date:  2021-05-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.